AI ultrasound could revolutionize breast cancer screening in poor regions
NCT ID NCT07462351
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether non-experts using AI-supported ultrasound can effectively screen for breast cancer in communities with limited access to radiologists. About 4,800 women, both with and without symptoms, will receive a clinical breast exam and AI-guided ultrasound. The goal is to see if this approach can accurately detect cancer, potentially making screening more affordable and widespread.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-supported point-of-care ultrasound (POCUS)
What this could lead to
If successful, this could provide a low-cost, accessible breast cancer screening method for communities with limited resources.
What could go wrong
This is an early feasibility study, not a treatment trial. The AI tool may not match expert radiologists, and false positives or negatives could occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arba Minch University and health care facilities and markets in the Gamo Zone
RECRUITINGArba Minch, Gamo Zone, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••